Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-3ASR Sep 5, 2025 S-3ASR
S-8 Aug 6, 2025 S-8
10-Q Aug 6, 2025 10-Q
8-K Aug 6, 2025 8-K
8-K Jul 30, 2025 8-K
4 Jul 2, 2025 4
4 Jul 2, 2025 4
4 Jul 2, 2025 4
4 Jul 2, 2025 4
4 Jul 2, 2025 4
4 Jul 2, 2025 4
8-K Jun 24, 2025 8-K
4 Jun 11, 2025 OWNERSHIP DOCUMENT
8-K May 20, 2025 8-K
SCHEDULE 13G May 15, 2025
10-Q May 6, 2025 10-Q
8-K May 6, 2025 8-K
ARS Apr 25, 2025 ARS
DEFA14A Apr 25, 2025 DEFA14A
DEF 14A Apr 25, 2025 DEF 14A
SCHEDULE 13G Apr 11, 2025
4 Apr 9, 2025 4
3 Apr 9, 2025 3
8-K Apr 7, 2025 8-K
4 Mar 12, 2025 4
← Newer Page 4 of 33 · 815 filings Older →